HemaSphere (Jun 2022)
S168: ERYTHROPOIETIN STIMULATION AGENTS SIGNIFICANTLY IMPROVES OUTCOME IN LOWER RISK MDS.
- H. Garelius,
- A. Smith,
- T. Bagguley,
- A. Taylor,
- P. Fenaux,
- D. Bowen,
- A. Symeonidis,
- M. Mittelmann,
- R. Stauder,
- J. Čermák,
- G. Sanz,
- S. Langemeijer,
- L. Malcovati,
- U. Germing,
- R. Itzykson,
- A. Guerci-Bresler,
- D. Culligan,
- I. Kotsianidis,
- K. Koinig Mag,
- C. van Marrewijk,
- S. Crouch,
- T. de Witte,
- E. Hellström-Lindberg
Affiliations
- H. Garelius
- 1 Section of Hematology, Specialist Medicine, Sahlgrenska University hospital, Göteborg, Sweden
- A. Smith
- 2 Department of Health Sciences, University of York, York, United Kingdom
- T. Bagguley
- 2 Department of Health Sciences, University of York, York, United Kingdom
- A. Taylor
- 2 Department of Health Sciences, University of York, York, United Kingdom
- P. Fenaux
- 3 Service d’Hematologie, Hôpital Saint-Loius, Assistance Publique des Hopitaux de Paris (AP-HP) and Universite Paris
- D. Bowen
- 4 St.James’s Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom
- A. Symeonidis
- 5 Department of Medicine, Division of hematology, University of Patras Medical Scholl, Patras, Greece
- M. Mittelmann
- 6 Department of Medicine, Tel Aviv Sourasky (Ichilov) Medical Center and Sackler Medical Faculty, Tel Aviv University, Tel Aviv, Israel
- R. Stauder
- 7 Paris, France
- J. Čermák
- 8 Dep. of Clinical Hematology, Institute of Hematology & Blood Transfusion, Prague, Czechia
- G. Sanz
- 9 Department of Haematology, Hospital Universitario y Politécnico La Fe, Valencia, Spain
- S. Langemeijer
- 10 Department of Hematolog, Radboud university medical center, Nijmegen, Netherlands
- L. Malcovati
- 11 Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo,University of Pavia, Pavia, Italy
- U. Germing
- 12 Department of Haematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Düsseldorf, Germany
- R. Itzykson
- 13 Service d’Hématologie, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP) and Université Paris
- A. Guerci-Bresler
- 14 Service d’Hématologie, Centre Hospitalier Universitaire Brabois Vandoeuvre, Nancy, France
- D. Culligan
- 15 Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom
- I. Kotsianidis
- 16 Dep. of Hematology, Democritus University of Thrace Medical School, University Hospital of Alexandroupolis, Alexandroupolis, Greece
- K. Koinig Mag
- 17 Department of Internal Medicine V (Hematology and Oncology), Medical University Innsbruc, Innsbruck, Austria
- C. van Marrewijk
- 18 Department of Haematology, Radboud university medical center
- S. Crouch
- 2 Department of Health Sciences, University of York, York, United Kingdom
- T. de Witte
- 19 Department of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud university medical cente, Nijmegen, Netherlands
- E. Hellström-Lindberg
- 20 Department of Medicine, Div. Hematology, Karolinska Institutet, Stockholm, Sweden
- DOI
- https://doi.org/10.1097/01.HS9.0000843564.40783.b4
- Journal volume & issue
-
Vol. 6
pp. 69 – 70
Abstract
No abstracts available.